Results

Reset All Filters

Manufacturer:Adooq remove filter

Oncology

Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.

The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.

To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.

Click on the organs and learn more about cancer types

General information

Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.

Relevant products for oncology research

Name	Type	Specific against	Item no.	Amount	Price
CDDO-dhTFEA 100mg	Inhibitors	Other	A19751-100 Adooq	100 mg	Login Compare	CDDO-dhTFEA 100mg
PROTAC RAR Degrader-1 1mg	Inhibitors	Other	A19757-1 Adooq	1 mg	Login Compare	PROTAC RAR Degrader-1 1mg
PROTAC RAR Degrader-1 5mg	Inhibitors	Other	A19757-5 Adooq	5 mg	Login Compare	PROTAC RAR Degrader-1 5mg
PROTAC RAR Degrader-1 10mg	Inhibitors	Other	A19757-10 Adooq	10 mg	Login Compare	PROTAC RAR Degrader-1 10mg
PROTAC RAR Degrader-1 50mg	Inhibitors	Other	A19757-50 Adooq	50 mg	Login Compare	PROTAC RAR Degrader-1 50mg
CGRP antagonist 1 1mg	Inhibitors	Other	A19760-1 Adooq	1 mg	Login Compare	CGRP antagonist 1 1mg
CGRP antagonist 1 5mg	Inhibitors	Other	A19760-5 Adooq	5 mg	Login Compare	CGRP antagonist 1 5mg
CGRP antagonist 1 10mg	Inhibitors	Other	A19760-10 Adooq	10 mg	Login Compare	CGRP antagonist 1 10mg
UbcH5c-IN-1 1mg	Inhibitors	Other	A19784-1 Adooq	1 mg	Login Compare	UbcH5c-IN-1 1mg
UbcH5c-IN-1 5mg	Inhibitors	Other	A19784-5 Adooq	5 mg	Login Compare	UbcH5c-IN-1 5mg
UbcH5c-IN-1 10mg	Inhibitors	Other	A19784-10 Adooq	10 mg	Login Compare	UbcH5c-IN-1 10mg
CD73-IN-1 1mg	Inhibitors	Other	A19794-1 Adooq	1 mg	Login Compare	CD73-IN-1 1mg
CD73-IN-1 5mg	Inhibitors	Other	A19794-5 Adooq	5 mg	Login Compare	CD73-IN-1 5mg
CD73-IN-1 10mg	Inhibitors	Other	A19794-10 Adooq	10 mg	Login Compare	CD73-IN-1 10mg
CD73-IN-1 50mg	Inhibitors	Other	A19794-50 Adooq	50 mg	Login Compare	CD73-IN-1 50mg
PDGFRα kinase inhibitor 1 5mg	Inhibitors	Other	A19632-5 Adooq	5 mg	Login Compare	PDGFRα kinase inhibitor 1 5mg
PDGFRα kinase inhibitor 1 10mg	Inhibitors	Other	A19632-10 Adooq	10 mg	Login Compare	PDGFRα kinase inhibitor 1 10mg
PDGFRα kinase inhibitor 1 50mg	Inhibitors	Other	A19632-50 Adooq	50 mg	Login Compare	PDGFRα kinase inhibitor 1 50mg
PDGFRα kinase inhibitor 1 100mg	Inhibitors	Other	A19632-100 Adooq	100 mg	Login Compare	PDGFRα kinase inhibitor 1 100mg
ERK1/2 inhibitor 1 25mg	Inhibitors	Other	A19596-25 Adooq	25 mg	Login Compare	ERK1/2 inhibitor 1 25mg
ERK1/2 inhibitor 1 50mg	Inhibitors	Other	A19596-50 Adooq	50 mg	Login Compare	ERK1/2 inhibitor 1 50mg
ERK1/2 inhibitor 1 100mg	Inhibitors	Other	A19596-100 Adooq	100 mg	Login Compare	ERK1/2 inhibitor 1 100mg
PI3K/mTOR Inhibitor-2 1mg	Inhibitors	Other	A19621-1 Adooq	1 mg	Login Compare	PI3K/mTOR Inhibitor-2 1mg
PI3K/mTOR Inhibitor-2 25mg	Inhibitors	Other	A19621-25 Adooq	25 mg	Login Compare	PI3K/mTOR Inhibitor-2 25mg
PI3K/mTOR Inhibitor-2 200mg	Inhibitors	Other	A19621-200 Adooq	200 mg	Login Compare	PI3K/mTOR Inhibitor-2 200mg

Name Price

CDDO-dhTFEA 100mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19751-100
Amount	100 mg
Available

PROTAC RAR Degrader-1 1mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19757-1
Amount	1 mg
Available

PROTAC RAR Degrader-1 5mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19757-5
Amount	5 mg
Available

PROTAC RAR Degrader-1 10mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19757-10
Amount	10 mg
Available

PROTAC RAR Degrader-1 50mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19757-50
Amount	50 mg
Available

CGRP antagonist 1 1mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19760-1
Amount	1 mg
Available

CGRP antagonist 1 5mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19760-5
Amount	5 mg
Available

CGRP antagonist 1 10mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19760-10
Amount	10 mg
Available

UbcH5c-IN-1 1mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19784-1
Amount	1 mg
Available

UbcH5c-IN-1 5mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19784-5
Amount	5 mg
Available

UbcH5c-IN-1 10mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19784-10
Amount	10 mg
Available

CD73-IN-1 1mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19794-1
Amount	1 mg
Available

CD73-IN-1 5mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19794-5
Amount	5 mg
Available

CD73-IN-1 10mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19794-10
Amount	10 mg
Available

CD73-IN-1 50mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19794-50
Amount	50 mg
Available

PDGFRα kinase inhibitor 1 5mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19632-5
Amount	5 mg
Available

PDGFRα kinase inhibitor 1 10mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19632-10
Amount	10 mg
Available

PDGFRα kinase inhibitor 1 50mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19632-50
Amount	50 mg
Available

PDGFRα kinase inhibitor 1 100mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19632-100
Amount	100 mg
Available

ERK1/2 inhibitor 1 25mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19596-25
Amount	25 mg
Available

ERK1/2 inhibitor 1 50mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19596-50
Amount	50 mg
Available

ERK1/2 inhibitor 1 100mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19596-100
Amount	100 mg
Available

PI3K/mTOR Inhibitor-2 1mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19621-1
Amount	1 mg
Available

PI3K/mTOR Inhibitor-2 25mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19621-25
Amount	25 mg
Available

PI3K/mTOR Inhibitor-2 200mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19621-200
Amount	200 mg
Available

Oncology

Click on the organs and learn more about cancer types

General information

Relevant products for oncology research

Contact

About Hölzel

Service

Infodesk

REGISTER & SECURE BENEFITS

Filter Results

Oncology

Click on the organs and learn more about cancer types

General information

Relevant products for oncology research

Contact

About Hölzel

Service

Infodesk